Addus HomeCare (NASDAQ:ADUS) Coverage Initiated at BMO Capital Markets

Equities research analysts at BMO Capital Markets assumed coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a note issued to investors on Thursday, MarketBeat Ratings reports. The firm set a “market perform” rating and a $120.00 price target on the stock. BMO Capital Markets’ target price would suggest a potential upside of 10.02% from the stock’s previous close.

ADUS has been the subject of a number of other reports. Barclays boosted their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Stephens reissued an “overweight” rating and issued a $140.00 target price on shares of Addus HomeCare in a report on Wednesday, September 3rd. Royal Bank Of Canada raised their target price on Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $137.11.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $109.07 on Thursday. The firm’s 50-day moving average price is $115.15 and its 200-day moving average price is $113.02. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The company has a market cap of $2.02 billion, a PE ratio of 24.08, a PEG ratio of 1.87 and a beta of 0.88. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The firm had revenue of $362.30 million during the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 earnings per share. As a group, analysts anticipate that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the sale, the executive vice president owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer directly owned 166,461 shares in the company, valued at $19,134,691.95. This represents a 13.06% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 34,310 shares of company stock valued at $3,958,375 in the last ninety days. Corporate insiders own 4.50% of the company’s stock.

Institutional Trading of Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of ADUS. Tributary Capital Management LLC grew its stake in Addus HomeCare by 114.1% during the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after acquiring an additional 212,192 shares in the last quarter. Nuveen LLC purchased a new stake in Addus HomeCare in the 1st quarter worth $16,155,000. Capital Research Global Investors boosted its holdings in shares of Addus HomeCare by 9.0% during the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Addus HomeCare by 25.8% during the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company’s stock valued at $46,670,000 after purchasing an additional 96,823 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in shares of Addus HomeCare by 1,229.4% in the first quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company’s stock worth $9,978,000 after purchasing an additional 93,308 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.